Filing metadata

Accession number
0001209191-22-020840
Form type
Form 4
Filer
Milestone Pharmaceuticals Inc.
CIK
CIK 1408443
Filed
Mar 23, 2022
Reporting period
Mar 21, 2022
Description
Insider transaction

Explore SEC Filings Hub